Scarica l'app Stockscreener
14.92
0.53%
-0.08
Dopo l'orario di chiusura:
14.90
-0.02
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché INMD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$15.00
Aprire:
$15.03
Volume 24 ore:
767.53K
Relative Volume:
0.56
Capitalizzazione di mercato:
$868.09M
Reddito:
$492.05M
Utile/perdita netta:
$197.92M
Rapporto P/E:
6.487
EPS:
2.3
Flusso di cassa netto:
$176.12M
1 W Prestazione:
+4.34%
1M Prestazione:
+0.27%
6M Prestazione:
-22.77%
1 anno Prestazione:
-19.31%
Intervallo 1D:
$14.76
$15.11
Intervallo di 1 settimana:
$14.06
$15.22
Portata 52W:
$13.68
$19.85
Inmode Ltd Stock (INMD) Company Profile
Confronta INMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
14.92 | 868.09M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
129.05 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.53 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.11 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.50 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-04-28 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Iniziato | BTIG Research | Buy |
| 2024-07-23 | Downgrade | Jefferies | Buy → Hold |
| 2023-11-03 | Downgrade | UBS | Buy → Neutral |
| 2023-10-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-02-17 | Downgrade | Needham | Buy → Hold |
| 2022-12-21 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-05-18 | Iniziato | Needham | Buy |
| 2019-09-03 | Iniziato | Barclays | Overweight |
| 2019-09-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-09-03 | Iniziato | Robert W. Baird | Outperform |
| 2019-09-03 | Iniziato | UBS | Buy |
Mostra tutto
Inmode Ltd Borsa (INMD) Ultime notizie
Where are the Opportunities in (INMD) - news.stocktradersdaily.com
DEADLINE ALERT: Bernstein Liebhard LLP Reminds InMode Ltd. Investors of Upcoming Deadline - ACCESS Newswire
DOMA Perpetual urges InMode to replace CEO, resume buybacks - Investing.com
DOMA Perpetual urges InMode to replace CEO, resume buybacks By Investing.com - Investing.com India
InMode (INMD) Urged by Major Shareholder to Revamp Leadership an - GuruFocus
Shareholders that lost money on InMode Ltd. (INMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
InMode Shareholder DOMA Perpetual Seeks CEO Ouster, Buyback Resumption - marketscreener.com
Doma Perpetual Sends Letter To The Board Of Inmode To Resume Share Repurchase Program - marketscreener.com
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program - PR Newswire
Shareholders that lost money on InMode Ltd.(INMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Indo-Asian News Service - Indo-Asian News Service (IANS)
InMode Ltd. has secured a significant legal victory against counterfeit sellers of its Morpheus8 devices, reinforcing its commitment to consumer safety and intellectual property protection. - medianet.com.au
InMode wins case against DHGate sellers over counterfeit products - MSN
InMode to Present at Upcoming Investor Conferences and Events - Longview News-Journal
InMode (INMD) Wins Legal Battle Against Counterfeit Sellers - GuruFocus
We Think That There Are More Issues For InMode (NASDAQ:INMD) Than Just Sluggish Earnings - Yahoo Finance
InMode Granted Injunction Against Counterfeit Sellers of Morpheus8 Products - marketscreener.com
InMode (INMD) Secures Legal Victory Against Counterfeiters | INM - GuruFocus
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 - GuruFocus
InMode wins court case against counterfeit sellers - Investing.com Australia
InMode wins court case against counterfeit sellers By Investing.com - Investing.com South Africa
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges – Company AnnouncementFT.com - Financial Times
InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M - Seeking Alpha
InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth - Seeking Alpha
(INMD) Trading Signals - news.stocktradersdaily.com
Canaccord cuts InMode stock target to $15, maintains hold rating By Investing.com - Investing.com South Africa
InMode Ltd. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
InMode Reports Q1 2025 Financial Results Amid Challenges - TipRanks
Canaccord cuts InMode stock target to $15, maintains hold rating - Investing.com
InMode (INMD) Target Price Cut by Barclays Amidst Demand Concern - GuruFocus
InMode (INMD) Target Price Cut by Barclays Amidst Demand Concerns | INMD Stock News - GuruFocus
UBS Adjusts InMode Price Target to $16.25 From $19, Maintains Neutral Rating - marketscreener.com
InMode (INMD) Price Target Reduced by UBS Amid Uncertain Near-Te - GuruFocus
BTIG cuts InMode stock rating amid challenging market By Investing.com - Investing.com Nigeria
BTIG cuts InMode stock rating amid challenging market - Investing.com
InMode Ltd. (NASDAQ:INMD) Q1 2025 Earnings Call Transcript - Insider Monkey
InMode (INMD) Price Target Reduced Amid Ongoing Challenges | INM - GuruFocus
BTIG Research Downgrades InMode to Neutral From Buy - marketscreener.com
InMode (INMD) Price Target Reduced Amid Ongoing Challenges | INMD Stock News - GuruFocus
InMode (INMD) Faces Downgrade Amid Challenging Market Conditions - GuruFocus
InMode Q1 Earnings: Short-Term Catalysts Have Vanished (Rating Downgrade) (NASDAQ:INMD) - Seeking Alpha
InMode Shares Dip Over 11% After Earnings Miss Expectations - Finimize
InMode (INMD) Revises Profit Guidance Amid Economic Hurdles - GuruFocus
InMode revenue decreases 3% to USD 77.9 million in Q1 2025 - Medical Buyer
InMode Ltd (INMD) Shares Gap Down to $14.355 on Apr 28 - GuruFocus
InMode: Equity Value Hinges On Cash, Not Future Prospects (Rating Downgrade) - Seeking Alpha
InMode slides on lowered full year profit guidance - MSN
INMD Beats Revenue Expectations, Faces U.S. Market Challenges | - GuruFocus
Baird Downgrades InMode to Neutral From Outperform, $16 Price Target; Shares Fall - marketscreener.com
InMode slides on full year profit guidance cut (INMD:NASDAQ) - Seeking Alpha
InMode: Q1 Earnings Snapshot - The Wilton Bulletin
Inmode Ltd Azioni (INMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.70%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):